Early pharmacological blockade of the CXCL12-CXCR4 axis attenuates vertebral hypercalcification in a zebrafish model of pseudoxanthoma elasticum

Pseudoxanthoma elasticum (PXE), caused by pathogenic variants in ABCC6, is characterized by pathological ectopic calcification with poorly understood mechanisms and no effective therapies. To address this, we developed the first zebrafish model of human PXE by introducing the pathogenic ABCC6 point...

Full description

Saved in:
Bibliographic Details
Main Authors: Jianjian Sun, Jichang Huang, Renjie Zhang, Shubin Zhang, Tao P. Zhong, Ping Zhu
Format: Article
Language:English
Published: Elsevier 2025-09-01
Series:Biochemistry and Biophysics Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2405580825002912
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849222555306557440
author Jianjian Sun
Jichang Huang
Renjie Zhang
Shubin Zhang
Tao P. Zhong
Ping Zhu
author_facet Jianjian Sun
Jichang Huang
Renjie Zhang
Shubin Zhang
Tao P. Zhong
Ping Zhu
author_sort Jianjian Sun
collection DOAJ
description Pseudoxanthoma elasticum (PXE), caused by pathogenic variants in ABCC6, is characterized by pathological ectopic calcification with poorly understood mechanisms and no effective therapies. To address this, we developed the first zebrafish model of human PXE by introducing the pathogenic ABCC6 point mutation (abcc6aR1463C/R1463C, F2 generation) using the highly efficient zhyA3A-CBE5 cytosine base editor. Three mutant types (Type1-Type3, T1-T3) stratified by calcification severity, exhibited reduced levels of the calcification inhibitors vitamin K1 (VK1) and carboxylated matrix Gla protein (cMGP), which were inversely correlated with the severity of calcification. Vertebral transcriptomics revealed dysregulated pathways related to ossification, bone remodeling-associated extracellular matrix (ECM), and immune responses, with the CXCL12-CXCR4 axis identified as a pivotal signaling hub. Early pharmacological blockade of CXCR4 using AMD3100 initiated at 5 days post-fertilization (dpf), significantly attenuated hypercalcification, whereas late intervention (from 1 month post-fertilization, mpf) demonstrated minimal efficacy. Notably, dual-target therapy combining VK1 and AMD3100 synergistically reduced hypercalcification in T3 mutants, surpassing the effects of either monotherapy. This synergy indicates functional crosstalk between vitamin K metabolism and CXCL12–CXCR4 signaling. These findings identify the CXCL12-CXCR4 axis as a therapeutic target for ectopic calcification and propose a novel dual-target strategy for PXE treatment.
format Article
id doaj-art-2d2bb0491f8f401e91e9f4e4452dcf65
institution Kabale University
issn 2405-5808
language English
publishDate 2025-09-01
publisher Elsevier
record_format Article
series Biochemistry and Biophysics Reports
spelling doaj-art-2d2bb0491f8f401e91e9f4e4452dcf652025-08-26T04:14:26ZengElsevierBiochemistry and Biophysics Reports2405-58082025-09-014310220410.1016/j.bbrep.2025.102204Early pharmacological blockade of the CXCL12-CXCR4 axis attenuates vertebral hypercalcification in a zebrafish model of pseudoxanthoma elasticumJianjian Sun0Jichang Huang1Renjie Zhang2Shubin Zhang3Tao P. Zhong4Ping Zhu5Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, Guangdong, 510100, China; Guangdong Provincial Key Laboratory of Pathogenesis, Targeted Prevention and Treatment of Heart Disease, Guangzhou Key Laboratory of Cardiac Pathogenesis and Prevention, Guangzhou, Guangdong, 510100, China; Shanghai Key Laboratory of Regulatory Biology, Institute of Molecular Medicine, East China Normal University School of Life Sciences, Shanghai, 200241, China; Corresponding author. Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, Guangdong, 510100, China.Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, Guangdong, 510100, China; Guangdong Provincial Key Laboratory of Pathogenesis, Targeted Prevention and Treatment of Heart Disease, Guangzhou Key Laboratory of Cardiac Pathogenesis and Prevention, Guangzhou, Guangdong, 510100, ChinaShanghai Key Laboratory of Regulatory Biology, Institute of Molecular Medicine, East China Normal University School of Life Sciences, Shanghai, 200241, ChinaShanghai Key Laboratory of Regulatory Biology, Institute of Molecular Medicine, East China Normal University School of Life Sciences, Shanghai, 200241, ChinaShanghai Key Laboratory of Regulatory Biology, Institute of Molecular Medicine, East China Normal University School of Life Sciences, Shanghai, 200241, China; Corresponding author. Shanghai Key Laboratory of Regulatory Biology, Institute of Molecular Medicine, East China Normal University School of Life Sciences, Shanghai, 200241, China.Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, Guangdong, 510100, China; Guangdong Provincial Key Laboratory of Pathogenesis, Targeted Prevention and Treatment of Heart Disease, Guangzhou Key Laboratory of Cardiac Pathogenesis and Prevention, Guangzhou, Guangdong, 510100, China; Corresponding author. Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, Guangdong, 510100, China.Pseudoxanthoma elasticum (PXE), caused by pathogenic variants in ABCC6, is characterized by pathological ectopic calcification with poorly understood mechanisms and no effective therapies. To address this, we developed the first zebrafish model of human PXE by introducing the pathogenic ABCC6 point mutation (abcc6aR1463C/R1463C, F2 generation) using the highly efficient zhyA3A-CBE5 cytosine base editor. Three mutant types (Type1-Type3, T1-T3) stratified by calcification severity, exhibited reduced levels of the calcification inhibitors vitamin K1 (VK1) and carboxylated matrix Gla protein (cMGP), which were inversely correlated with the severity of calcification. Vertebral transcriptomics revealed dysregulated pathways related to ossification, bone remodeling-associated extracellular matrix (ECM), and immune responses, with the CXCL12-CXCR4 axis identified as a pivotal signaling hub. Early pharmacological blockade of CXCR4 using AMD3100 initiated at 5 days post-fertilization (dpf), significantly attenuated hypercalcification, whereas late intervention (from 1 month post-fertilization, mpf) demonstrated minimal efficacy. Notably, dual-target therapy combining VK1 and AMD3100 synergistically reduced hypercalcification in T3 mutants, surpassing the effects of either monotherapy. This synergy indicates functional crosstalk between vitamin K metabolism and CXCL12–CXCR4 signaling. These findings identify the CXCL12-CXCR4 axis as a therapeutic target for ectopic calcification and propose a novel dual-target strategy for PXE treatment.http://www.sciencedirect.com/science/article/pii/S2405580825002912PXEABCC6Ectopic calcificationVitamin K1CXCL12-CXCR4 axis
spellingShingle Jianjian Sun
Jichang Huang
Renjie Zhang
Shubin Zhang
Tao P. Zhong
Ping Zhu
Early pharmacological blockade of the CXCL12-CXCR4 axis attenuates vertebral hypercalcification in a zebrafish model of pseudoxanthoma elasticum
Biochemistry and Biophysics Reports
PXE
ABCC6
Ectopic calcification
Vitamin K1
CXCL12-CXCR4 axis
title Early pharmacological blockade of the CXCL12-CXCR4 axis attenuates vertebral hypercalcification in a zebrafish model of pseudoxanthoma elasticum
title_full Early pharmacological blockade of the CXCL12-CXCR4 axis attenuates vertebral hypercalcification in a zebrafish model of pseudoxanthoma elasticum
title_fullStr Early pharmacological blockade of the CXCL12-CXCR4 axis attenuates vertebral hypercalcification in a zebrafish model of pseudoxanthoma elasticum
title_full_unstemmed Early pharmacological blockade of the CXCL12-CXCR4 axis attenuates vertebral hypercalcification in a zebrafish model of pseudoxanthoma elasticum
title_short Early pharmacological blockade of the CXCL12-CXCR4 axis attenuates vertebral hypercalcification in a zebrafish model of pseudoxanthoma elasticum
title_sort early pharmacological blockade of the cxcl12 cxcr4 axis attenuates vertebral hypercalcification in a zebrafish model of pseudoxanthoma elasticum
topic PXE
ABCC6
Ectopic calcification
Vitamin K1
CXCL12-CXCR4 axis
url http://www.sciencedirect.com/science/article/pii/S2405580825002912
work_keys_str_mv AT jianjiansun earlypharmacologicalblockadeofthecxcl12cxcr4axisattenuatesvertebralhypercalcificationinazebrafishmodelofpseudoxanthomaelasticum
AT jichanghuang earlypharmacologicalblockadeofthecxcl12cxcr4axisattenuatesvertebralhypercalcificationinazebrafishmodelofpseudoxanthomaelasticum
AT renjiezhang earlypharmacologicalblockadeofthecxcl12cxcr4axisattenuatesvertebralhypercalcificationinazebrafishmodelofpseudoxanthomaelasticum
AT shubinzhang earlypharmacologicalblockadeofthecxcl12cxcr4axisattenuatesvertebralhypercalcificationinazebrafishmodelofpseudoxanthomaelasticum
AT taopzhong earlypharmacologicalblockadeofthecxcl12cxcr4axisattenuatesvertebralhypercalcificationinazebrafishmodelofpseudoxanthomaelasticum
AT pingzhu earlypharmacologicalblockadeofthecxcl12cxcr4axisattenuatesvertebralhypercalcificationinazebrafishmodelofpseudoxanthomaelasticum